1. Product Application and Approval
1.1. Biologics License Applications (BLA) Process (CBER)
1.2. Premarket Approval (PMA) Process
1.3. New Drug Application (NDA) Process
1.4. 510(k) Process
1.5. Advertising & Labeling (Biologics)
1.6. Manufacturers Assistance (CBER)
2. Postmarketing, Compliance and Enforcement
2.1. Biologics Post-Market Activities
2.2. Biologic Product Security
2.3. CBER-Regulated Products: Shortages and Discontinuations
2.4. Compliance Programs (CBER)
2.5. Impact of Severe Weather Conditions on Biological Products
2.6. Exporting CBER-Regulated Products
2.7. Lot Distribution Database (LDD)
2.8. Product Surveillance (CBER)
2.9. Recalls (Biologics)
2.10. Report a Problem to the Center for Biologics Evaluation & Research
2.11. Direct Recall Classification Program
2.12. Safety & Availability (Biologics)
2.13. Untitled Letters (CBER)
2.14. Unique Device Identification - UDI
3. Spotlight
3.1. CBER Key Staff Directory
4. Recall & Alerts
4.1. Recalls (Biologics)
4.2. CBER-Regulated Products: Shortage and Discontinuations
4.3. Report a Problem to the Center for Biologics Evaluation & Research
4.4. Direct Recall Classification Program
5. Approvals & Clearances
5.1. Biologics Products & Establishments
6. Laws, Regulation, Guidance and Other information
6.1. Guidance
6.1.1. Biologics
6.1.1.1. General biologics guidances
6.1.1.2. Allerginics
6.1.1.3. Blood
6.1.1.4. Cellular and Gene therapy
6.1.1.5. Tissue
6.1.1.6. Vaccine and related biological product
6.1.1.7. Xenotransplantation
6.1.1.8. Guidance agenda : guidance documents is planning to publish
6.1.1.9. Regen Biologics
6.1.2. General
6.1.2.1. Advisory committee
6.1.2.2. Clinical trials
6.1.2.3. Combination products
6.1.2.4. General and cross-cutting topics
6.1.2.5. Import and Export
6.1.2.6. International council for Harmonization
6.1.2.6.1. efficacy
6.1.2.6.2. Joint safety/Efficacy
6.1.2.6.3. quailty
6.1.2.6.4. safety
6.1.2.7. Veterinary International Conference on Harmonization
6.1.3. Other topic area guidances
6.1.3.1. animal & veterinary
6.1.3.2. combination products
6.1.3.3. cosmetics
6.1.3.4. drugs
6.1.3.5. food
6.1.3.6. medical devices
6.1.3.7. radiation-emitting products
6.1.4. Related links